EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of FcRn Binding on Ocular Disposition of Monoclonal Antibodies

Sanika Naware, Saurav Kulkarni, Sahil Salvi, Dhvani Patel, Dhaval K Shah iD

Antibodies · 25.03.2026 · 15 (2) · 27

DOI: 10.3390/antib15020027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibodies, online erschienen am 25.03.2026. Verfasst von Sanika Naware und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY 14214…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Protein Therapeutics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The neonatal Fc receptor (FcRn) plays a crucial role in extending the systemic half-life of monoclonal antibodies (mAbs), but its influence on ocular distribution remains incompletely understood. This study investigated the impact of FcRn on the ocular disposition of mAbs following systemic administration in rabbits.

Methods

New Zealand White rabbits received a single intravenous dose (1 mg/kg) of either wild-type trastuzumab (TS-WT) or its FcRn non-binding variant (IHH). Plasma and ocular tissues (retina, iris–ciliary body, vitreous humor, aqueous humor, cornea, conjunctiva, and tears) were collected at terminal time points up to 336 h for TS-WT and 168 h for IHH. Antibody concentrations were quantified using a validated sandwich ELISA. Pharmacokinetic parameters and antibody biodistribution coefficients (ABC) were calculated to assess the FcRn-mediated effects on ocular distribution.

Results

TS-WT demonstrated 2-fold higher systemic exposure compared to IHH. The iris–ciliary body exhibited the highest absolute exposure for both antibodies, with TS-WT showing significantly higher accumulation (ABC0–168h: 14.95% vs. 8.89%). Retinal distribution remained comparable between antibodies (5.96% vs. 5.51%). Both antibodies were detectable in tears, with ABC value of ~4% reported for TS-WT. TS-WT also demonstrated markedly increased distribution in vitreous humor and tear fluid (3.5- and 5.5-fold higher ABC values, respectively) compared to IHH. The cornea (5.76% vs. 5.57%) and conjunctiva (7.71% vs. 7.21%) showed comparable relative distribution between TS-WT and IHH, while aqueous humor showed minimal differences (0.44% vs. 0.52%).

Conclusions

This investigation reveals distinct tissue-specific patterns of FcRn-mediated mAb distribution within the eye. FcRn binding significantly enhanced antibody distribution in ocular tissues, such as the iris–ciliary body, and tears, with less pronounced effects on the retina, cornea, conjunctiva and aqueous humor. These findings provide mechanistic insights for optimizing mAb-based therapeutics for ocular disease and understanding the ocular toxicity of mAb-based therapeutics, such as antibody–drug conjugates.

Schlagwörter

Stichwörter der Autor:innen

biodistributionmonoclonal antibodiesneonatal Fc receptorocular pharmacokineticsrabbittear fluid

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY 14214-8033, USA.

ORCID-Profile: Dhaval K Shah

Förderung

  • Center for Protein Therapeutics
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • NIGMS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NCI NIH HHS
  • Center for Protein Therapeutics at the University of Buffalo
  • National Institute of General Medical Sciences
  • National Cancer Institute

Zitieren

APA

Naware, S., Kulkarni, S., Salvi, S., Patel, D., & Shah, D. K. (2026). The Effect of FcRn Binding on Ocular Disposition of Monoclonal Antibodies. Antibodies, 15(2), 27. https://doi.org/10.3390/antib15020027

Vancouver

Naware S, Kulkarni S, Salvi S, Patel D, Shah DK. The Effect of FcRn Binding on Ocular Disposition of Monoclonal Antibodies. Antibodies. 2026;15(2):27. doi:10.3390/antib15020027

BibTeX
@article{Naware2026,
  author = {Naware, Sanika and Kulkarni, Saurav and Salvi, Sahil and Patel, Dhvani and Shah, Dhaval K},
  title = {The Effect of FcRn Binding on Ocular Disposition of Monoclonal Antibodies},
  journal = {Antibodies},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {27},
  doi = {10.3390/antib15020027}
}
Kostenlos starten →